hill center2016

March 1-2, 2018

(Links will be activated as information is finalized)

Symposium Agenda


Hotel Information

The 2018 Cardiovascular Bioengineering (CVBE) Symposium is scheduled to be held on the campus of The University of Alabama at Birmingham (UAB) March 1-2, 2018. This will be the 4th Anniversary of the Symposium.  The uniqueness of the proposed CVBE symposium lies in its combination of top researchers in cardiovascular bioengineering with underrepresented trainees in the field. Trainees are graduate students and post-doctoral fellows in the cardiovascular sciences and biomedical engineering at UAB. The symposium will provide a forum for UAB trainees and junior investigators to present their work in the areas of gene editing, induced pluripotent stem cells, and cardiac stem cells in the context of heart failure as well general topics in cardiovascular bioengineering. This conference has previously been held separately from (but in conjunction with) the NIH NHLBI progenitor cell translational consortium (NIH PCTC) for the past 3 years1, 2, 3 by UAB. The meeting became an annual public symposium in 2016, and since 2016, this conference has been recognized as a unique public and recurring scientific symposium of stem cell and cardiovascular bioengineering. The conference in the past 2 years has added translational topics as well as the “bread and butter” of this meeting, which is basic stem cell bioengineering, molecular cardiovascular research, and tissue engineering. The conference has attracted the world leading scientists in field of cardiac stem cells. 1, 2, 3, 4   The conference topics started with tissue engineering, iPS cells,  cardiac development, and in the past two years has grown to include exosome, microRNAs, mitochondria,  cardiac gene and cardiac cell therapy. The attendance of this conference has climbed and, in 2017, we had attendance of nearly 130. As in past years, the conference will be held in March, and this year, will be held March 2 at the Hill Student Center on the campus of UAB. The planned agenda represents an ambitious, fast-paced meeting with 5 sessions over 1 day including the Keynote lecture. Young cardiovascular scientists will be highlighted through invited talks at each session.  Organizers of this meeting are Drs. Jianyi (Jay) Zhang (UAB), Tim Kamp (UW-Madison), Gangjian Qin (UAB), and Joel Berry (UAB). The proposal request constitutes approximately 25% of the total meeting budget, and as we have done over the last several years, support from this application will be used towards the cost of faculty travel and hotel only, for 2018, we aim at new Outreach Awards (minority travel awards) and Young Investigator Travel Awards, part of the National Hearth, Lung, and Blood Institute's Progenitor Cell Biology Consortium (PCBC), will be held March 1-2, 2018, at the UAB Hill Student Center (day 1) and the UAB Alumni House (day 2).


  1. Ogle BM, Bursac N, Domian I, Huang NF, Menasche P, Murry CE, Pruitt B, Radisic M, Wu JC, Wu SM, Zhang J, Zimmermann WH and Vunjak-Novakovic G. Distilling complexity to advance cardiac tissue engineering. Sci Transl Med. 2016;8:342ps13.
  2. Zhu W and Zhang J. Meeting Report for the 2017 National Institutes of Health National Heart, Lung, and Blood Institute Progenitor Cell Biology Consortium: Cardiovascular Bioengineering Workshop and Symposium. Circ Res. 2017;120:1709-1712.
  3. Kannappan R and Zhang J. Meeting Report for NIH 2016 Progenitor Cell Biology Consortium Cardiovascular Tissue Engineering 2016. Circ Res. 2016;119:981-983.
  4. Yanamandala M, Zhu W, Garry DJ, Kamp T, Hare JM, Jun HW, Yoon YS, Bursac N, Prabhu S, Dorn G, Kitsis R, Zhang J. Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering. Journal of the American College of Cardiology (JACC). 2017;70(6):766-775.